Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Lawyers Wrote 'Polite F-U Letters' to Help Big Pharma Fix Drug Prices, AGs Claim in Unredacted Suit | Connecticut Law Tribune
Teva considering $2B sale of active pharma ngredients unit | Seeking Alpha
US Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals Event App by Teva Pharmaceuticals USA, Inc.